Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study

Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study

Bibliographic Details
Main Authors:	Andrea Visentin, Vincenzo Nasillo, Monia Marchetti, Isacco Ferrarini, Rossella Paolini, Rosaria Sancetta, Gian Matteo Rigolin, Francesca Cibien, Marcello Riva, Chiara Briani, Serena Marinello, Francesco Piazza, Filippo Gherlinzoni, Mauro Krampera, Renato Bassan, Antonio Cuneo, Mario Luppi, Gianpietro Semenzato, Roberto Marasca, Livio Trentin
Format:	Article
Language:	English
Published:	Wiley 2020-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000395

Similar Items

Limbic Encephalitis with HU-Antibodies in T-cell Anaplastic Lymphoma. A Case Report
by: Carmela Gurrieri, et al.
Published: (2021-07-01)

Biophysical Characterization and Expression Analysis of Kv1.3 Potassium Channel in Primary Human Leukemic B Cells
by: Ildiko Szabo, et al.
Published: (2015-09-01)

Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence
by: Monia Marchetti, et al.
Published: (2022-04-01)

The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment
by: Isacco Ferrarini, et al.
Published: (2020-12-01)

Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis
by: Ester Lovato, et al.
Published: (2023-04-01)

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study
by: Andrea Visentin, et al.
Published: (2022-11-01)

P1183: CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS AND AT RELAPSE IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS OF THE “RETE EMATOLOGICA VENETA” (T-REV PROJECT).
by: Marcello Riva, et al.
Published: (2023-08-01)

Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma
by: Sabrina Manni, et al.
Published: (2021-10-01)

An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma
by: Isacco Ferrarini, et al.
Published: (2023-02-01)

Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice
by: Carlo Visco, et al.
Published: (2020-10-01)

Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma
by: Sabrina Manni, et al.
Published: (2022-08-01)

NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
by: Renato Zambello, et al.
Published: (2020-03-01)

Actionable Strategies to Target Multiple Myeloma Plasma Cell Resistance/Resilience to Stress: Insights From “Omics” Research
by: Sabrina Manni, et al.
Published: (2020-05-01)

COVID-19: room for treating T cell exhaustion?
by: Giovanni Riva, et al.
Published: (2020-05-01)

Linking COVID-19, monocyte activation and sepsis: MDW, a novel biomarker from cytometry
by: Giovanni Riva, et al.
Published: (2022-01-01)

Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1
by: Stefania Fiorcari, et al.
Published: (2022-01-01)

A Case of Hemophagocytic Lymphohistiocytosis Triggered by Disseminated Tuberculosis and Hairy Cell Leukaemia after SARS-CoV2 Infection
by: Alessandro Cellini, et al.
Published: (2022-01-01)

Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
by: Colpo Anna, et al.
Published: (2010-10-01)

Innovative Combinations, Cellular Therapies and Bispecific Antibodies for Chronic Lymphocytic Leukemia: A Narrative Review
by: Andrea Visentin, et al.
Published: (2024-03-01)

COVID-19: more than a cytokine storm
by: Giovanni Riva, et al.
Published: (2020-09-01)

Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study
by: Federica Lessi, et al.
Published: (2021-08-01)

CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis
by: Zambello Renato, et al.
Published: (2005-02-01)

A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction
by: Jessica Ceccato, et al.
Published: (2022-10-01)

From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance
by: Andrea Visentin, et al.
Published: (2022-03-01)

Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital
by: Nicolò Danesin, et al.
Published: (2023-10-01)

Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia
by: Mario Angelo Pagano, et al.
Published: (2022-10-01)

Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges
by: Giovanni Riva, et al.
Published: (2021-09-01)

CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma
by: Anna Fregnani, et al.
Published: (2022-08-01)

Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
by: Giulia Bega, et al.
Published: (2021-12-01)

Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients
by: Isacco Ferrarini, et al.
Published: (2022-04-01)

<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
by: Fabio Forghieri, et al.
Published: (2020-11-01)

BTK Inhibitors Impair Platelet-Mediated Antifungal Activity
by: Vincenzo Nasillo, et al.
Published: (2022-03-01)

An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1–MECOM fusion transcripts
by: Fabio Forghieri, et al.
Published: (2014-01-01)

Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells.
by: Sabrina Manni, et al.
Published: (2013-01-01)

Burkitt lymphoma in adolescents and young adults: management challenges
by: Dozzo M, et al.
Published: (2016-12-01)

P1111: WALDENSTRÖM MACROGLOBULINEMIA IN THE VERY ELDERLY (≥75-YEAR-OLD): DESCRIPTION OF CLINICAL FEATURES AND SURVIVAL OUTCOMES IN A CASE SERIES FROM AN ITALIAN ACADEMIC CENTER
by: Nicolò Danesin, et al.
Published: (2023-08-01)

CK2β-regulated signaling controls B cell differentiation and function
by: Laura Quotti Tubi, et al.
Published: (2023-01-01)

A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results
by: Mariarosaria Sessa, et al.
Published: (2020-12-01)

S312: IS BREXUCABTAGENE AUTOLEUCEL A COST-EFFECTIVE TREATMENT FOR REFRACTORY/RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA? A PHARMACOECONOMIC ANALYSIS IN THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM.
by: Monia Marchetti
Published: (2023-08-01)

Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies
by: Vincenzo Nasillo, et al.
Published: (2021-02-01)